Eyecare Catalyst Partners

You built the science. We deliver the exit.

In eyecare, capital and regulatory approvals are no longer what decides the outcome. Execution between the investment and the exit is. We fund, embed, and operate alongside a capable company, and carry it to an acquisition at its true worth.

Now reviewing a small number of companies for the current cohort.

The mandate

Great eyecare technologies rarely fail because the science was wrong.

They fail in the stretch between the check and the exit — where a company has to build a commercial engine, hit the milestones that de-risk it, and reach a buyer before the money runs out. Capital is abundant. Approval is achievable. Execution is the scarce, decisive asset.

The model

One accountable team, from investment through exit.

01

Fund

Private capital directed at the specific inflection points that matter — faster and simpler than a strategic's multi-month cycle.

02

Embed

Hands-on commercial, regulatory, hiring and partnership work with clear ownership. We operate — we do not merely advise.

03

De-risk

Revenue, repeatability and validation — the buyer-readable proof the market can actually price.

04

Exit

Positioning and process discipline for the strategic acquirers, sold at a premium rather than a fire-sale.

Why us?

We've been in your seat, and across the table.

The Buyer

Corporate Venture Capitalist

Knows what makes a company acquirable, and what makes acquirers wait.

The Seller

Founder to exit

Has walked the runway cliff, the raise, and the sale personally.

The Scaler

Large-scale commercial leadership

Builds the revenue engine the cautionary tales never had.

Who should apply

Built for founders near a value-inflection point.

The right fit is a company where capital & focused execution can materially change the outcome within a defined window.

  • Technologies that leverage vision, imaging, and eye-derived data.
  • Defensible clinical performance, IP, data or regulatory progress.
  • A credible commercial path that needs sharper execution.
  • A near-term milestone that can unlock strategic interest.
  • Founders who want an operating partner, not only a check.
Submit an application

Start a confidential conversation.

Send your pitch deck and a one-pager. Tell us where the company is today and what the next inflection point requires. If there's a fit, a partner responds directly to arrange the first call.

applications@eyecarecatalyst.com
Attach: pitch deckAttach: one-pagerReviewed under strict confidence

Strictly confidential. What you send is used only to evaluate a potential partnership, and is never shared outside our partners.